Gilead Sciences (GILD) Avoids Billions in US Taxes - Bloomberg
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) stock is on watch following a Bloomberg article that pointed out the company avoided billions in US taxes on its Hepatitis C treatment by booking profits overseas. The article cites its 10-K filing yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) April weekly option implied volatility into quarter results
- Amazon is a more profitable company; Citi lifts price target
- Apple (AAPL) Announces Special Event For May 7 - Reports
Create E-mail Alert Related Categories
General NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
